Merkel Cell Carcinoma (MCC) is an uncommon but highly malignant skin cancer originating from Merkel cells in the epidermis. Strongly associated with the Merkel cell polyomavirus (MCPyV), present in around 80% of cases, MCC typically affects older adults and those with compromised immune systems. Recent strides in cancer research have led to promising immunotherapies, including checkpoint inhibitors, which enhance the immune system's ability to identify and eradicate cancer cells. Early diagnosis is critical due to MCC's propensity for rapid metastasis, complicating treatment. Research efforts continue to focus on unraveling the molecular underpinnings of MCC, with the goal of developing more effective therapeutic strategies and improving patient survival rates.



Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States
Title : Graphene quantum dots: A new frontier for photodynamic therapy
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil